TRK-820, a selective kappa opioid receptor agonist, could effectively ameliorate L-DOPA-induced dyskinesia symptoms in a rat model of Parkinson's disease

✍ Scribed by Ken Ikeda; Satoru Yoshikawa; Takahiro Kurokawa; Natsumi Yuzawa; Kaoru Nakao; Hidenori Mochizuki

• Book ID: 113588400
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 707 KB
• Volume: 620
• Category: Article
• ISSN: 0014-2999
• DOI: 10.1016/j.ejphar.2009.08.013